top of page

Search Results

Results found for "Nobel Prize"

  • Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem

    Lefkowitz was awarded the Nobel Prize in Chemistry, shared with Brian Kobilka, for studies of G protein-coupled Lefkowitz learned at 5 AM on October 10, 2012, that he had won the Nobel Prize in Chemistry, his first The question he had been asked for years — when are you going to win the Nobel Prize? Prize?" Lefkowitz, M.D., 2012 Nobel Prize in Chemistry, which he shared with Dr. Brian Kobilka .

  • Dr. Oliver Hartley | Dr. GPCR Ecosystem

    as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter (Nobel Prize for Chemistry, 2018).

  • Dr. Bruno Giros | Dr. GPCR Ecosystem

    professor at Duke University in North Carolina, working with Marc Caron and Robert Lefkowitz (2012 Nobel Prize in Chemistry) to characterize several neurotransmitter transporters and kinases and establish and has received several distinctions, including the CNRS silver medal, the FRM "Young Researcher" prize

  • Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem

    During dinner with colleagues and Alfred Gillman , co-recipient of the 1994 Nobel Prize in Physiology Today, Paul and his team focus on previously unrecognized receptors with the hopes to use these as novel

  • Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem

    afraid to be afraid 01:26:00 Three aha moments: socks, a forgotten sample, and one cold email to a Nobel "I can't believe you won the Nobel Prize. ." — Said to Boucard by a fellow Nobel laureate's wife, at a ceremony at Stanford, following the 2013 prize announcement "If you willingly put yourself in a situation where you're willing to take risks, Alfred Gilman , Nobel Laureate for his discovery of G proteins, Dr.

  • Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem

    GPCR research through Heidi Hamm's lab - and why the committee said G proteins had already won their Nobel Prize 12:39 Co-founding CUE Biotech and Caden Biosciences - allosteric modulator screens and G-protein

  • Dr. Randy Hall | Dr. GPCR Ecosystem

    training at Duke University, where he studied the regulation of adrenergic receptors in the laboratory of Nobel Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished

  • Julia Gardner | Dr. GPCR Ecosystem

    at as the first-ever summer intern at Septerna, the GPCR-based biotechnology company founded by Duke Nobel

  • Dr. Sudha Shenoy | Dr. GPCR Ecosystem

    Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr.

  • Our History | Dr. GPCR Ecosystem

    Lefkowitz , 2012 Nobel Laureate in Chemistry. 2nd Annual Summit Sep 13–19, 2021 — The 2nd Dr. Brian Kobilka , 2012 Nobel Laureate in Chemistry.

  • Dr. Kathleen Caron | Dr. GPCR Ecosystem

    She pursued postdoctoral training with Nobel Laureate Dr.

  • Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem

    to be working alongside the very talented team at Orion who translate important GPCR research into novel She pursued postdoctoral training with Nobel Laureate Dr.

  • Dr. Stuart Maudsley | Dr. GPCR Ecosystem

    At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based forming the basis of a new technology-based start-up company, HeptOME , to help screen and develop novel

  • Dr. Stuart Maudsley | Dr. GPCR Ecosystem

    At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based forming the basis of a new technology-based start-up company, HeptOME , to help screen and develop novel

  • Dr. Stuart Maudsley | Dr. GPCR Ecosystem

    At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based forming the basis of a new technology-based start-up company, HeptOME , to help screen and develop novel

  • Vaithish Velazhahan | Dr. GPCR Ecosystem

    He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination Vaithish has been recognized with the MRC LMB's Max Perutz Prize for outstanding Ph.D. work and has been

  • Yao Lu (Jackie) | Dr. GPCR Ecosystem

    Ph.D. student, at Monash University, Australia, investigating the role of functional selectivity in a novel Her work involves the pharmacological and structural characterisation of novel putative antipsychotic molecular explanation of small molecules for their pre-clinical efficacy and to support the design of novel

  • Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem

    and a famously generous field 22:55 NIH postdoc: Class B GPCRs, mentorship, and conversations with Nobel

  • Dr. Mark Connor | Dr. GPCR Ecosystem

    Graeme Henderson (Bristol, opioids and Ca signaling) and Mac Christie (Sydney, opioids in neurons, novel Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with a focus on efficacy and novel targets.

  • University Pricing | Dr. GPCR Ecosystem

    Jobs Board Complete GPCR Coverage Community Tools Career Matchmaker Frequently Asked Questions Premium Pricing

  • Dr. Stephane Angers | Dr. GPCR Ecosystem

    Moon , where he identified and characterized novel components of the Wnt signaling pathway and a new His pioneer work led to the development of novel antibody molecules blocking and activating the Wnt pathway

  • Dr. Prasenjit Saha | Dr. GPCR Ecosystem

    My research goal is to identify novel cellular target receptors of human gut microbe-derived metabolites During my post-doctoral research, I was part of a study that identified the receptors of a novel human

  • Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem

    structural biology, pharmacology, and pharmacoepidemiology with innovative computational methods to gain novel Ph.D. with David Gloriam at the Department of Drug Design and Pharmacology in Copenhagen, he worked on novel He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

  • Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem

    Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel During her time at Providence College, she received the Walsh Grant Fellowship to develop novel methods

  • Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem

    Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced a series of novel couple fluorophores to expressed receptors and other membrane proteins has allowed the creation of novel

  • Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem

    Do not pursue something "completely novel" as a junior scientist. His retrospective advice is to pick something novel but "still in the tent" — close enough to what the selectivity 33:05 HSP90 as Pac-Man — co-chaperones and the AHA1 clue 38:52 Picking projects that are "novel "Pick something that is novel, but is sort of still in the tent."

  • Dr. Neil Grimsey | Dr. GPCR Ecosystem

    Neil Grimsey " During my postdoctoral studies at USCD, I discovered a novel GPCR-dependent atypical kinase

  • When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem

    He is particularly excited by the novel application of PAMs in chronic and neuropathic pain models , “Allosteric modulation in GPCRs is so novel and so exciting. Clements is a behavioral pharmacologist who uses in vitro and in vivo models to discover and characterize novel

  • Dr. Graeme Milligan | Dr. GPCR Ecosystem

    Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for

  • Scott Struthers | Dr. GPCR Ecosystem

    chair at Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel

bottom of page